The bone marrow biopsy market exhibits a comprehensive range of products, including needles, instruments, biopsy guns, and procedure trays. Procedure types encompass hip biopsy, breastbone (sternum) biopsy, percutaneous trephine biopsy, tibia (shin) biopsy, and more. This diverse product and procedure landscape reflects the market's multifaceted nature, catering to varied diagnostic needs. The availability of specialized tools for distinct procedures underscores the industry's commitment to providing effective solutions for bone marrow examinations across different anatomical sites.
Access full Report @ https://www.databridgemarketresearch.com/reports/global-bone-marrow-biopsy-market
Data Bridge Market Research analyses that the Global Bone Marrow Biopsy Market value, which was USD 1.10 billion in 2021, is expected to reach the value of USD 1.79 billion by 2029, at a CAGR of 6.3% during the forecast period 2022-2029. Increasing awareness of the crucial role of early blood disorder detection propels the bone marrow biopsy market. As more people recognize the significance of timely screenings, there's a heightened demand for bone marrow biopsies, driving market growth and advancing healthcare diagnostics.
Key Findings of the Study
Growing aging population is expected to drive the market's growth rate
The aging global population is a significant driver for the expansion of the bone marrow biopsy market. With an increase in age, there's a higher incidence of diseases linked to bone marrow abnormalities, such as leukemia and myeloma. As the elderly demographic grows, so does the demand for bone marrow biopsies to diagnose and manage these conditions. This demographic shift underscores the market's role in addressing the healthcare needs of an aging population, driving market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
BD (U.S.), Medtronic (Netherland), ARGON MEDICAL (U.S.), Teleflex Incorporated (U.S.), Cardinal Health (U.S.), Merit Medical Systems (U.S.), Cook (U.S.), MDL SRL. (U.S.), SOMATEX Medical Technologies GmbH (Deutschland), Biopsybell (U.S.), STERYLAB S.r.l. (Italy), Tsunami Medical Srl (Italy), weLLgo Medical Products GmbH (Germany), Hiprove (Germnay), Shanghai Mekon Medical Devices Co., Ltd. (China), Egemen International (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global bone marrow biopsy market is segmented on the basis of product type, procedure, biopsy type, site, technique, age, application, and end user.
- On the basis of product type, the global bone marrow biopsy market is segmented into needles, instruments, biopsy gun, procedure trays, others
- On the basis of procedure, the global bone marrow biopsy market is segmented into hip biopsy, breastbone (sternum) biopsy, percutaneous trephine biopsy, tibia (shin) biopsy, and others
- On the basis of biopsy type, the global bone marrow biopsy market is segmented into core needle biopsy, vacuum-assisted biopsy (VAB), and fine needle aspiration biopsy
- On the basis of site, the global bone marrow biopsy market is segmented into posterior iliac crest, anterior iliac crest, calcaneus, distal tibia, proximal tibia, proximal humerus, and others
- On the basis of technique, the global bone marrow biopsy market is segmented into flow cytometry, fluorescence in situ hybridization (Fish), polymerase chain reaction (PCR), karyotype test, and other
- On the basis of age, the global bone marrow biopsy market is segmented into geriatric, adult, and pediatric
- On the basis of application, the global bone marrow biopsy market is segmented into lymphoma disease, leukemia, polycythemia vera, multiple myeloma, thrombocythemia, myelofibrosis, aplastic anemia, and others
- On the basis of end user, the global bone marrow biopsy market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, academic and research organizations, and others
Major Players
Data Bridge Market Research recognizes the following companies as the global bone marrow biopsy market players in global bone marrow biopsy market are BD (U.S.), Medtronic (Netherland), ARGON MEDICAL (U.S.), Teleflex Incorporated (U.S.), Cardinal Health (U.S.), Merit Medical Systems (U.S.), Cook (U.S.), MDL SRL. (U.S.).
Market Development
- In May 2022, Argon Medical formed a strategic partnership with Terumo India to expand its presence in the Indian medical market. This partnership enables the distribution of a wide range of medical products, including guide wires, IVC (Inferior Vena Cava) devices, and biopsy needles for bone and soft tissues. Through this venture, the companies aim to enhance access to critical medical supplies and contribute to healthcare advancements in India
Regional Analysis
Geographically, the countries covered in the global bone marrow biopsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global bone marrow biopsy market during the forecast period 2022-2029
North America dominates the bone marrow biopsy market, driven by widespread adoption for diagnosing abnormal blood cell counts, identifying iron deficiencies, and detecting blood-related cancers. The region's high acceptance of bone marrow biopsy stems from its efficacy in diagnosing conditions affecting blood-forming tissues. Additionally, the procedure is pivotal for assessing chemotherapy effects. This dominance reflects North America's leadership in advancing medical practices and underscores the critical role of bone marrow biopsy in comprehensive healthcare diagnostics.
Asia-Pacific is expected to dominate the global bone marrow biopsy market in the forecast period 2022-2029
The Asia-Pacific is expected to dominate the bone marrow biopsy market from 2022 to 2029. This growth is attributed to the rising prevalence of blood cancer and an increased number of bone marrow biopsies performed in the region. The escalating demand for diagnostic procedures underscores the importance of bone marrow biopsy in identifying and managing blood-related disorders. This trend positions the Asia-Pacific market as a key player in advancing healthcare diagnostics.
For more detailed information about the global bone marrow biopsy market report, click here – https://www.databridgemarketresearch.com/reports/global-bone-marrow-biopsy-market
